Lab-on-a-chip: emerging analytical platforms for immune-mediated diseases.

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Clinical Diagnostics

Background:

• Miniaturization of analytical procedures offers benefits like reduced sample/reagent use and faster analysis times.
• Lab-on-a-chip (LoC) devices, built using microelectronics techniques, integrate biochemical analysis operations.
• These platforms are crucial for diagnosing both common and rare diseases.

Purpose of the Study:

• To review the applications of Lab-on-a-chip technology in the clinical diagnostics of immune-mediated diseases.
• To provide an overview of how LoC can simplify and improve complex diagnostic procedures.

Main Methods:

• Review of existing literature on Lab-on-a-chip applications in clinical diagnostics.
• Analysis of the integration of microfluidic principles with diagnostic assays.
• Focus on immune-mediated disease diagnostics and procedural simplification.

Main Results:

• Lab-on-a-chip technology demonstrates significant potential in enhancing diagnostic capabilities.
• Specific LoC applications can streamline and simplify intricate diagnostic workflows for immune-mediated conditions.
• The miniaturization inherent in LoC contributes to reduced resource consumption and increased efficiency.

Conclusions:

• Lab-on-a-chip technology is a valuable tool for advancing clinical diagnostics, particularly for immune-mediated diseases.
• The integration of LoC platforms promises to revolutionize diagnostic procedures, making them more accessible and efficient.
• Further development and adoption of LoC technologies are expected to significantly impact healthcare outcomes.